Unibios Holdings S.A vs Veralto: Fair Value & Quality
Both stocks run through our valuation models. Here is how Unibios Holdings S.A (BIOSK) and Veralto (VLTO) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees Veralto as the less overvalued of the two: Unibios Holdings S.A trades at €2.62 versus a fair value of €1.59 (-39%), while Veralto trades at $98.34 versus $69.11 (-30%).
Unibios Holdings S.A
BIOSK.AT · EUR · Industrials
-39%
upside to fair value
overvalued
Price€2.62
Fair Value€1.59
Quality40/100
Veralto
VLTO · USD · Industrials
-30%
upside to fair value
overvalued
Price$98.34
Fair Value$69.11
Quality71/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Unibios Holdings S.AVeralto
Valuation
27.2×P/E (TTM)23.7×
3.55×P/S (TTM)4.00×
2.64×P/B7.20×
26.0×EV/EBITDA16.2×
—PEG2.70×
—Dividend yield0.5%
—Dividend per share$0.48
Profitability
12%Net margin17%
5%Operating margin24%
8%Return on equity36%
3%Return on assets11%
Growth
-16%Revenue growth (YoY)7%
7.3%Avg. growth/yr (3Y)4.2%
13.7%Avg. growth/yr (5Y)4.8%
Balance & size
0.22×Debt / equity0.64×
$49MMarket cap$22B
expensiveGrowth qualityhealthy
Veralto leads: 5 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Unibios Holdings S.Aof which business quality 40 · market factors 48Veraltoof which business quality 70 · market factors 53
ProfitabilityMargins and returns on capital today
37
75
Quality GrowthAre margins and returns improving?
46
36
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
35
72
Low VolatilityCalm price path (market factor)
78
80
MomentumPrice trend over the last 3–12 months (market factor)
35
41
52W MomentumDistance to the 52-week high (market factor)
37
44
Net IssuanceBuybacks instead of dilution
58
77
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Unibios Holdings S.A
DCF Models€0.23
Earnings-Based€1.06
Multiples€1.68
Asset-Based€0.72
Economic Profit€0.82
Growth Earnings€1.75
14 of 15 models see the stock below the current price.
Veralto
DCF Models$65.58
Earnings-Based$47.47
Dividend Discount$6.75
Multiples$64.44
Asset-Based$8.47
Growth DCF$56.57
Economic Profit$46.75
Growth Earnings$65.88
25 of 25 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Unibios Holdings S.A
Bear €1.19Fair Value €1.59Bull €1.99
€2.62 = current price (white tick)
Veralto
Bear $46.91Fair Value $69.11Bull $87.04
$98.34 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Unibios Holdings S.A · Industrials
Quality score40 · bottom 25%
Fair value upside-39% · below median
Veralto · Industrials
Quality score71 · Top 25%
Fair value upside-30% · below median
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees Veralto as the less overvalued of the two: Unibios Holdings S.A trades at €2.62 versus a fair value of €1.59 (-39%), while Veralto trades at $98.34 versus $69.11 (-30%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
